SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.

ABSTRACT:

SUBMITTER: Behrens GM 

PROVIDER: S-EPMC8372487 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature